Prognostic Value of Heart Rate Variability in Patients With Cancer

Overview

Journal J Clin Neurophysiol

Specialties Neurology
Physiology

Date 2015 Dec 3

PMID 26629761

Citations 33

Authors

Ying Guo

Shalini Koshy

David Hui

J Lynn Palmer

Ki Shin

Mehtap Bozkurt

Syed Wamique Yusuf

Affiliations

Soon will be listed here.

Abstract

Introduction: Previous studies have shown that autonomic dysfunction is associated with shorter survival in patients with advanced cancer. We examined the association between heart rate variability, a measure of autonomic function, and survival in a large cohort of patients with cancer.

Methods: We retrospectively examined the records of 651 patients with cancer who had undergone ambulatory electrocardiogram monitoring for 20 to 24 hours. Time domain heart rate variability (SD of normal-to-normal beat interval [SDNN]) was calculated using power spectral analysis. Survival data were compared between patients with SDNN ≥ 70 milliseconds (Group 1, n = 520) and SDNN < 70 milliseconds (Group 2, n = 131).

Results: Two groups were similar in most variables, except that patients in group 2 had a significantly higher percentage of male patients (P = 0.03), hematological malignancies (P = 0.04), and use of non-selective serotonin reuptake inhibitor antidepressants (P = 0.04). Patients in group 2 had a significantly shorter survival rate (25% of patients in group 2 died by 18.7 weeks vs. 78.9 weeks in group 1 patients; P < 0.0001). Multivariate analysis showed that SDNN < 70 milliseconds remained significant for survival (hazard ratio 1.9 [95% confidence interval: 1.4-2.5]) independent of age, cancer stage, and performance status.

Conclusion: The presence of cancer in combination with decreased heart rate variability (SDNN < 70 milliseconds) is associated with shorter survival time.

Citing Articles

Heart Rate Variability as a Digital Biomarker in Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation.

Taylor M, Bradford M, Zhou C, Fladeboe K, Wittig J, Baker K Cancer Med. 2025; 14(4):e70609.

PMID: 39981705 PMC: 11843223. DOI: 10.1002/cam4.70609.

Cancer and Stress: Understanding the Connections and Interventions.

DAndre S, Ellsworth L, Kirsch J, Montane H, Kruger M, Donovan K Am J Lifestyle Med. 2024; :15598276241304373.

PMID: 39651486 PMC: 11624519. DOI: 10.1177/15598276241304373.

How to properly evaluate cardiac vagal tone in oncology studies: a state-of-the-art review.

Martinez P, Grinand M, Cheggour S, Taieb J, Gourjon G J Natl Cancer Cent. 2024; 4(1):36-46.

PMID: 39036385 PMC: 11256691. DOI: 10.1016/j.jncc.2024.02.002.

Evaluation of Anorexia in Cancer and Its Association with Autonomic Nervous System Activity Assessed by Heart Rate Variability.

Molfino A, Gallicchio C, Imbimbo G, Melena M, Antonini S, Gigante A Nutrients. 2023; 15(23).

PMID: 38068794 PMC: 10707971. DOI: 10.3390/nu15234936.

The Assessment of Heart Rate Variability in Patients with Pancreatic Cancer.

Petrescu M, Udristoiu I, Militaru F, Petrescu A, Tartea G, Raicea V Curr Health Sci J. 2023; 49(2):172-178.

PMID: 37779831 PMC: 10541060. DOI: 10.12865/CHSJ.49.02.172.

References

England J, Gronseth G, Franklin G, Carter G, Kinsella L, Cohen J . Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular.... PM R. 2009; 1(1):14-22. DOI: 10.1016/j.pmrj.2008.11.011. View

Frenneaux M . Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart. 2004; 90(11):1248-55. PMC: 1768543. DOI: 10.1136/hrt.2003.026146. View

Licht C, de Geus E, van Dyck R, Penninx B . Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry. 2010; 68(9):861-8. DOI: 10.1016/j.biopsych.2010.06.032. View

Strasser F, Palmer J, Schover L, Yusuf S, Pisters K, Vassilopoulou-Sellin R . The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer. 2006; 107(12):2949-57. DOI: 10.1002/cncr.22339. View

Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M . The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci. 2011; 166(1-2):96-9. DOI: 10.1016/j.autneu.2011.10.002. View

Wang Y, Wu H, Huang E, Kou Y, Hseu S . Heart rate variability is associated with survival in patients with brain metastasis: a preliminary report. Biomed Res Int. 2013; 2013:503421. PMC: 3786541. DOI: 10.1155/2013/503421. View

Nelson K, Walsh D, Sheehan F . Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support Care Cancer. 2002; 10(6):455-61. DOI: 10.1007/s00520-002-0340-9. View

Lee J, Kim K, Hong J, Lee W, Koo S . Comparison of electroacupuncture frequency-related effects on heart rate variability in healthy volunteers: a randomized clinical trial. J Acupunct Meridian Stud. 2011; 4(2):107-15. DOI: 10.1016/S2005-2901(11)60016-2. View

Munk P, Butt N, Larsen A . High-intensity interval exercise training improves heart rate variability in patients following percutaneous coronary intervention for angina pectoris. Int J Cardiol. 2009; 145(2):312-314. DOI: 10.1016/j.ijcard.2009.11.015. View

10.

Lazoglu A, Glace B, Gleim G, Coplan N . Exercise and heart rate variability. Am Heart J. 1996; 131(4):825-6. DOI: 10.1016/s0002-8703(96)90294-x. View

11.

Bruera E, Chadwick S, Fox R, Hanson J, Macdonald N . Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 1986; 70(12):1383-7. View

12.

Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R . Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion. 2001; 63(1):35-42. DOI: 10.1159/000051870. View

13.

Niederer D, Vogt L, Thiel C, Schmidt K, Bernhorster M, Lungwitz A . Exercise effects on HRV in cancer patients. Int J Sports Med. 2012; 34(1):68-73. DOI: 10.1055/s-0032-1314816. View

14.

Guo Y, Palmer J, Strasser F, Yusuf S, Bruera E . Heart rate variability as a measure of autonomic dysfunction in men with advanced cancer. Eur J Cancer Care (Engl). 2013; 22(5):612-6. PMC: 3745803. DOI: 10.1111/ecc.12066. View

15.

Krantz D, Whittaker K, Francis J, Rutledge T, Johnson B, Barrow G . Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study. Heart. 2009; 95(23):1901-6. PMC: 2784030. DOI: 10.1136/hrt.2009.176040. View

16.

Nuver J, Smit A, Sleijfer D, van Gessel A, van Roon A, van der Meer J . Left ventricular and cardiac autonomic function in survivors of testicular cancer. Eur J Clin Invest. 2005; 35(2):99-103. DOI: 10.1111/j.1365-2362.2005.01460.x. View

17.

Chen Y, Ho C, Hsu H, Huang P, Lin C, Liu C . Objective palliative prognostic score among patients with advanced cancer. J Pain Symptom Manage. 2014; 49(4):690-6. DOI: 10.1016/j.jpainsymman.2014.08.017. View

18.

Huikuri H, Kessler K, Terracall E, Castellanos A, Linnaluoto M, Myerburg R . Reproducibility and circadian rhythm of heart rate variability in healthy subjects. Am J Cardiol. 1990; 65(5):391-3. DOI: 10.1016/0002-9149(90)90308-n. View

19.

Bauer A, Kantelhardt J, Barthel P, Schneider R, Makikallio T, Ulm K . Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006; 367(9523):1674-81. DOI: 10.1016/S0140-6736(06)68735-7. View

20.

Hui D, Elsayem A, Li Z, De La Cruz M, Palmer J, Bruera E . Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer. 2010; 116(8):2036-43. PMC: 2854875. DOI: 10.1002/cncr.24942. View